在数据挖掘的背景下发现植物化学品对微RNA的抗癌作用
Yumi Sakai1,2, Kurataka Otsuka1,2,3,4
1Laboratory of Biomolecular Signaling, Tokyo NODAI Research Institute, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya, Tokyo 156-8502, Japan.
Nutrients
|December 31, 2025
概括
人工智能发现了新型植物化学物质,包括菲塞,格拉布里丁和西利比宁,它们调节结肠癌细胞中的微RNA (miRNA). 这些化合物显示出基于饮食的疾病预防策略的潜力.
科学领域:
- 营养科学 营养科学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 微RNA (miRNA) 与包括癌症在内的各种人类疾病有关,它们的表达特征与疾病预防有关.
- 了解微量和宏量营养素如何影响miRNA表达对于维持健康至关重要.
- 识别调节miRNA表达的特定植物化学物质是发现新的饮食功能的关键.
研究的目的:
- 使用人工智能识别用于结肠癌中调节微RNA (miRNA) 的新型植物化学物质.
- 用新的植物化学物质候选物治疗的结肠癌细胞中分析miRNA表达变化.
- 探索这些植物化学物质在以饮食为基础的健康促进和疾病预防方面的潜力.
主要方法:
- 利用人工智能选植物化学物质调节结肠癌中的miRNAs.
- 进行了下一代测序,以分析用植物化学候选物治疗的结肠癌细胞系中的miRNA表达.
- 进行路径分析,以了解被识别的植物化学物质影响的分子机制.
主要成果:
- 确定了三种植物化学物质 - - 菲塞丁,格拉布里丁和西利比宁 - - 抑制了结肠癌细胞的增殖,并改变了与癌症相关的miRNA表达.
- 观察到共同和化合物特定的miRNA表达特征,以响应每个植物化学物质.
- 发现这些植物化学物质会影响关键瘤发育途径,包括p53信号传递,亡和细胞衰老.
结论:
- 人工智能有效地发现了调节瘤相关miRNAs的新植物化学物质.
- 菲塞丁,格拉布里丁和西利比宁显示出作为影响结肠癌中miRNA表达的食剂的潜力.
- 对miRNA机制的进一步研究可以提高对促进健康和预防疾病的饮食营养素功能的理解.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


